Nosocomial bloodstream infections caused by Klebsiella pneumoniae:: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence -: art. no. 24

被引:87
作者
Marra, AR [1 ]
Wey, SB
Castelo, A
Gales, AC
Cal, RGR
do Carmo, JR
Edmond, MB
Pereira, CAP
机构
[1] Univ Fed Sao Paulo, EPM, HSP, Div Infect Dis, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, EPM, HSP, Clin Microbiol Lab, Sao Paulo, Brazil
[3] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil
[4] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
关键词
D O I
10.1186/1471-2334-6-24
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The frequency of ESBL producing Klebsiella pneumoniae bloodstream infections ( BSI) is high in Brazilian hospitals, however little is known regarding what role, if any, resistance plays in the expected outcome in hospitals with a high prevalence of these pathogens. Methods: From 1996 to 2001, hospital acquired K. pneumoniae BSI were evaluated retrospectively. Each patient was included only once at the time of BSI. ESBL producing strains were identified using the E-test method. The association of variables with the mortality related to bacteremia was included in a stepwise logistic regression model. Results: One hundred and eight hospital acquired K. pneumoniae BSI met criteria for inclusion. Fifty two percent were due to ESBL producing strains. The overall in-hospital mortality was 40.8%. Variables independently predicting death by multivariate analysis were the following: mechanical ventilation ( p = 0.001), number of comorbidities ( p = 0.003), antimicrobials prescribed before bacteremia ( p = 0.01) and fatal underlying disease ( p = 0.025). Conclusion: Bacteremia due to ESBL producing K. pneumoniae strains was not an independent predictor for death in patients with BSI. An increased mortality in hospital-acquired BSI by K. pneumoniae was related to the requirement for mechanical ventilation, more than two comorbidities, the previous use of two or more antibiotics, and the presence of a rapidly fatal disease.
引用
收藏
页数:8
相关论文
共 31 条
[1]  
Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610
[2]   Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].
Byl, B ;
Clevenbergh, P ;
Jacobs, F ;
Struelens, MJ ;
Zech, F ;
Kentos, A ;
Thys, JP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66
[3]   SHV-27, a novel cefotaxime-hydrolysing β-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital [J].
Corkill, JE ;
Cuevas, LE ;
Gurgel, RQ ;
Greensill, J ;
Hart, CA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) :463-465
[4]   Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen [J].
Cormican, MG ;
Marshall, SA ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :1880-1884
[5]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome [J].
Du, B ;
Long, Y ;
Liu, HZ ;
Chen, DC ;
Liu, DW ;
Xu, YC ;
Xie, XL .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1718-1723
[6]  
GALES AC, 1997, BRAZ J INFECT DIS, V1, P196
[7]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[8]   A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome [J].
Garrouste-Orgeas, M ;
Chevret, S ;
Mainardi, JL ;
Timsit, JF ;
Misset, B ;
Carlet, J .
JOURNAL OF HOSPITAL INFECTION, 2000, 44 (03) :206-213
[9]   Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control [J].
Hansen, DS ;
Gottschau, A ;
Kolmos, HJ .
JOURNAL OF HOSPITAL INFECTION, 1998, 38 (02) :119-132
[10]   Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection [J].
Hyle, EP ;
Lipworth, AD ;
Zaoutis, TE ;
Nachamkin, I ;
Bilker, WB ;
Lautenbach, E .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1375-1380